Suchergebnisse - "Nagashima, Tamon"

PubPharm (16)

1

A Newly Developed Method-Based Xanthine Oxidoreductase Activities in Various Human Liver Diseases

enthalten in: Biomedicines | 2023

von Sato, K. | Naganuma, A. | Nagashima, T. | +11

2

Therapeutic efficacy of lenvatinib as third-line treatment after regorafenib for unresectable hepatocellular carcinoma progression

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2021

von Hiraoka, A. | Kumada, T. | Hatanaka, T. | +40

3

Lenvatinib for Hepatocellular Carcinoma Patients with Nonviral Infection Who Were Unlikely to Respond to Immunotherapy : A Retrospective, Comparative Study

enthalten in: Oncology | 2021

von Hatanaka, T. | Kakizaki, S. | Nagashima, T. | +9

4

The Role of the Albumin-Bilirubin Score for Predicting the Outcomes in Japanese Patients with Advanced Hepatocellular Carcinoma Treated with Ramucirumab : A Real-World Study

enthalten in: Oncology | 2021

von Hatanaka, T. | Naganuma, A. | Shibasaki, M. | +14

5

Follow-up after Direct-acting Antiviral Treatment for Chronic Hepatitis C Virus Infection : Most Patients Are Followed Appropriately

enthalten in: Internal medicine (Tokyo, Japan) | 2021

von Tojima, H. | Kakizaki, S. | Takakusagi, S. | +12

6

Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression

enthalten in: Hepatology Research | 2021

von Hiraoka, A. | Kumada, T. | Hatanaka, T. | +39

7

Liver Function Changes in Patients with Hepatocellular Carcinoma Treated with Lenvatinib : Predictive Factors of Progression to Child-Pugh Class B, the Formation of Ascites and the Candidates for the Post-Progression Treatment

enthalten in: Cancers | 2020

von Hatanaka, T. | Kakizaki, S. | Nagashima, T. | +10

8

Analyses of objective response rate, progression-free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib : A multicenter retrospective study

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2020

von Hatanaka, T. | Kakizaki, S. | Nagashima, T. | +10

9

Favorable outcome of retreatment by direct-acting antivirals for hepatitis C patients with daclatasvir plus asunaprevir combination therapy failure

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2020

von Tojima, H. | Kakizaki, S. | Takakusagi, S. | +12

10

Analyses of objective response rate, progression‐free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib : A multicenter retrospective study

enthalten in: Hepatology Research | 2020

von Hatanaka, T. | Kakizaki, S. | Nagashima, T. | +10